Global Androgenetic Alopecia Market, By Treatment (Minoxidil, Finasteride, Dutasteride, Oral Antiandrogens, Hair transplant, Low-level Laser Therapy, Counseling, and Others), Gender (Male and Female), Route of Administration (Oral and Topical), End-Users (Clinics, Hospitals, Diagnostic centres, Surgical centres, others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Androgenetic Alopecia Market
Global androgenetic alopecia market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 9.60% in the above mentioned forecast period.
Androgenetic Alopecia is a type of alopecia (hair loss) and a genetic condition which affects both men and women. It is usually referred to as ‘Male Pattern Hair Loss’ or ‘Female Pattern Hair Loss. It is characterised by receding hairline and continuous loss of hair from the crown and frontal scalp.
The Global androgenetic alopecia market will expand significantly due to increasing prevalence of alopecia. Increase in the healthcare expenditure, rise in geriatric population, technological advancement in hair treatment, and rising demand for surgical hair transplant are the factors driving the androgenetic alopecia market.
Rise in number of R&D activities, advancement in treatment facilities, and clinical trials on emerging drugs are the expected factors that will boost opportunities for the Global Androgenetic Alopecia Market in the forecast period of 2021-2028.
High cost of medication as well as treatment and severe side effects, reactions caused due to treatment will hamper the market growth and will further challenge the Global Androgenetic Alopecia Market in the forecast period mentioned above.
This androgenetic alopecia market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global androgenetic alopecia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Androgenetic Alopecia Market Scope and Market Size
The Androgenetic Alopecia Market is segmented on the basis of treatment, gender, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the androgenetic alopecia market is segmented into minoxidil, finasteride, dutasteride, oral antiandrogens, hair transplant, low-level laser therapy, counseling, and others.
- On the basis of gender, the androgenetic alopecia market is segmented into male and female.
- On the basis of route of administration, the androgenetic alopecia market is segmented into oral, and topical.
- On the basis of end-users, the androgenetic alopecia market is segmented into clinics, hospitals, diagnostic centres, surgical centres, and others.
- The androgenetic alopecia market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy, and online pharmacy.
Global Androgenetic Alopecia Market Country Level Analysis
Global androgenetic alopecia market is analyzed and market size information is provided by the country, treatment, gender, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Global Androgenetic Alopecia Market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the androgenetic alopecia market due to the existence of major key players, rise in the prevalence of hair loss cases, high disposable income of people, higher cost of treatments, and rise in the innovative therapeutic solutions due to well-developed healthcare infrastructure in this region. Global androgenetic alopecia market in the Asia-Pacific is expected to grow during the forecast period, because of advancement in treatment technologies, growing government support, rise in R&D activities, and rising healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global androgenetic alopecia market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Androgenetic Alopecia Market Share Analysis
Global androgenetic alopecia market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global androgenetic alopecia market.
The major players covered in the global androgenetic alopecia market report are Vitabiotics Ltd., Sun Pharmaceutical Industries Ltd., Merck Sharp & Dohme Corp., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Johnson & Johnson Private Limited, Phyto Ales Groupe, and Lifes2good, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-